The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
April 29th 2024
Asian men who have sex with men (MSM) who recently immigrated to Australia were found to have lower uptake of pre-exposure prophylaxis (PrEP).
NIH Launches Study to Compare 3 HIV Treatments in Pregnant Women
January 24th 2018The study will evaluate the current preferred first-line regimen for pregnant women recommended by the World Health Organization and 2 regimens containing newer antiretroviral drugs that are becoming more widely used.
Read More
Researchers Develop More Accurate Tool to Identify New HIV Infections
January 17th 2018Researchers at the Duke Human Vaccine Institute have developed a method that more accurately identifies new versus long-standing HIV infections, an important distinction when determining where to target public health initiatives and research.
Read More
More Than One-Third of Patients With HIV Did Not Receive HBV Vaccination
January 14th 2018Although people with HIV are more susceptible to the hepatitis B virus, there is a low prevalence of hepatitis B vaccination among patients receiving medical care for HIV infection in the United States, according to a study in Annals of Internal Medicine.
Read More
Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds
January 12th 2018The same mechanisms that cause those with long-term HIV infection to suffer higher rates of heart attacks or strokes put children born with disease at early risk of cardiovascular disease, according to a new study.
Read More
Gates Discusses the Hope of Using Immuno-Oncology for HIV Breakthroughs, and More
January 9th 2018While public funding through the National Institutes of Health has created a foundation for healthcare research, the private sector can benefit from getting more involved, said Bill Gates, philanthropist and co-founder of Microsoft.
Read More
Age 25 is Optimal for Screening Adolescents, Young Adults Without Identified Risk Factors for HIV
January 7th 2018Although an additional one-time screening at any age between 15 and 30 yields important gains in HIV diagnosis rates and life expectancy for HIV-infected people, screening at age 25 would provide the most favorable clinical outcomes and the best value for money, according to a study in the Journal of Adolescent Health.
Read More
Dr Thomas C. Quinn Identifies Barriers to Preventing Spread of HIV
January 1st 2018The biggest barriers to stopping the transmission of HIV are both the large population of infected people not receiving treatment and the lack of pre-exposure prophylaxis for high-risk individuals, said Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health.
Watch